TY - JOUR AU - Scheen, A. J. PY - 2015 DA - 2015// TI - Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus JO - Drugs VL - 75 UR - https://doi.org/10.1007/s40265-014-0337-y DO - 10.1007/s40265-014-0337-y ID - Scheen2015 ER - TY - JOUR AU - Inzucchi, S. E. AU - Zinman, B. AU - Wanner, C. AU - Ferrari, R. AU - Fitchett, D. AU - Hantel, S. AU - Espadero, R. M. AU - Woerle, H. J. AU - Broedl, U. C. AU - Johansen, O. E. PY - 2015 DA - 2015// TI - SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials JO - Diab Vasc Dis Res VL - 12 UR - https://doi.org/10.1177/1479164114559852 DO - 10.1177/1479164114559852 ID - Inzucchi2015 ER - TY - JOUR AU - Fioretto, P. AU - Giaccari, A. AU - Sesti, G. PY - 2015 DA - 2015// TI - Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus JO - Cardiovasc Diabetol VL - 14 UR - https://doi.org/10.1186/s12933-015-0297-x DO - 10.1186/s12933-015-0297-x ID - Fioretto2015 ER - TY - JOUR AU - Zinman, B. AU - Wanner, C. AU - Lachin, J. M. AU - Fitchett, D. AU - Bluhmki, E. AU - Hantel, S. AU - Mattheus, M. AU - Devins, T. AU - Johansen, O. E. AU - Woerle, H. J. PY - 2015 DA - 2015// TI - Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504720 DO - 10.1056/NEJMoa1504720 ID - Zinman2015 ER - TY - JOUR AU - Ptaszynska, A. AU - Hardy, E. AU - Johnsson, E. AU - Parikh, S. AU - List, J. PY - 2013 DA - 2013// TI - Effects of dapagliflozin on cardiovascular risk factors JO - Postgrad Med VL - 125 UR - https://doi.org/10.3810/pgm.2013.05.2667 DO - 10.3810/pgm.2013.05.2667 ID - Ptaszynska2013 ER - TY - JOUR AU - Hach, T. AU - Gerich, J. AU - Salsali, A. AU - Kim, G. AU - Hantel, S. AU - Woerle, H. AU - Broedl, U. C. PY - 2014 DA - 2014// TI - Empagliflozin improves glycemic parameters and cardiovascular risk factors in patients with type 2 diabetes (T2DM): pooled data from four pivotal phase III trials JO - Diabetologie und Stoffwechsel VL - 9 UR - https://doi.org/10.1055/s-0034-1374999 DO - 10.1055/s-0034-1374999 ID - Hach2014 ER - TY - JOUR AU - Turner, R. C. AU - Millns, H. AU - Neil, H. A. AU - Stratton, I. M. AU - Manley, S. E. AU - Matthews, D. R. AU - Holman, R. R. PY - 1998 DA - 1998// TI - Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) JO - BMJ VL - 316 UR - https://doi.org/10.1136/bmj.316.7134.823 DO - 10.1136/bmj.316.7134.823 ID - Turner1998 ER - TY - JOUR AU - Araki, A. AU - Iimuro, S. AU - Sakurai, T. AU - Umegaki, H. AU - Iijima, K. AU - Nakano, H. AU - Oba, K. AU - Yokono, K. AU - Sone, H. AU - Yamada, N. PY - 2012 DA - 2012// TI - Non-high-density lipoprotein cholesterol: an important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patients JO - Geriatr Gerontol In. VL - 12 UR - https://doi.org/10.1111/j.1447-0594.2011.00809.x DO - 10.1111/j.1447-0594.2011.00809.x ID - Araki2012 ER - TY - JOUR AU - Austin, M. A. AU - Breslow, J. L. AU - Hennekens, C. H. AU - Buring, J. E. AU - Willett, W. C. AU - Krauss, R. M. PY - 1988 DA - 1988// TI - Low-density lipoprotein subclass patterns and risk of myocardial infarction JO - JAMA VL - 260 UR - https://doi.org/10.1001/jama.1988.03410130125037 DO - 10.1001/jama.1988.03410130125037 ID - Austin1988 ER - TY - JOUR AU - Griffin, B. A. PY - 1999 DA - 1999// TI - Lipoprotein atherogenicity: an overview of current mechanisms JO - Proc Nutr Soc VL - 58 UR - https://doi.org/10.1079/PNS19990022 DO - 10.1079/PNS19990022 ID - Griffin1999 ER - TY - JOUR AU - Boizel, R. AU - Benhamou, P. Y. AU - Lardy, B. AU - Laporte, F. AU - Foulon, T. AU - Halimi, S. PY - 2000 DA - 2000// TI - Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels JO - Diabetes Care VL - 23 UR - https://doi.org/10.2337/diacare.23.11.1679 DO - 10.2337/diacare.23.11.1679 ID - Boizel2000 ER - TY - JOUR AU - Duez, H. AU - Lamarche, B. AU - Uffelman, K. D. AU - Valero, R. AU - Cohn, J. S. AU - Lewis, G. F. PY - 2006 DA - 2006// TI - Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans JO - Arterioscler Thromb Vasc Biol VL - 26 UR - https://doi.org/10.1161/01.ATV.0000222015.76038.14 DO - 10.1161/01.ATV.0000222015.76038.14 ID - Duez2006 ER - TY - JOUR AU - Kathiresan, S. AU - Otvos, J. D. AU - Sullivan, L. M. AU - Keyes, M. J. AU - Schaefer, E. J. AU - Wilson, P. W. AU - D’Agostino, R. B. AU - Vasan, R. S. AU - Robins, S. J. PY - 2006 DA - 2006// TI - Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study JO - Circulation VL - 113 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.567107 DO - 10.1161/CIRCULATIONAHA.105.567107 ID - Kathiresan2006 ER - TY - JOUR AU - Krauss, R. M. PY - 2004 DA - 2004// TI - Lipids and lipoproteins in patients with type 2 diabetes JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.6.1496 DO - 10.2337/diacare.27.6.1496 ID - Krauss2004 ER - TY - JOUR AU - Ito, Y. AU - Fujimura, M. AU - Ohta, M. AU - Hirano, T. PY - 2011 DA - 2011// TI - Development of a homogeneous assay for measurement of small dense LDL cholesterol JO - Clin Chem VL - 57 UR - https://doi.org/10.1373/clinchem.2010.149559 DO - 10.1373/clinchem.2010.149559 ID - Ito2011 ER - TY - JOUR AU - Arai, H. AU - Kokubo, Y. AU - Watanabe, M. AU - Sawamura, T. AU - Ito, Y. AU - Minagawa, A. AU - Okamura, T. AU - Miyamato, Y. PY - 2013 DA - 2013// TI - Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: the suita study JO - J Atheroscler Thromb VL - 20 UR - https://doi.org/10.5551/jat.14936 DO - 10.5551/jat.14936 ID - Arai2013 ER - TY - JOUR AU - Tsai, M. Y. AU - Steffen, B. T. AU - Guan, W. AU - McClelland, R. L. AU - Warnick, R. AU - McConnell, J. AU - Hoefner, D. M. AU - Remaley, A. T. PY - 2014 DA - 2014// TI - New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the multi-ethnic Study of atherosclerosis JO - Arterioscler Thromb Vasc Biol VL - 34 UR - https://doi.org/10.1161/ATVBAHA.113.302401 DO - 10.1161/ATVBAHA.113.302401 ID - Tsai2014 ER - TY - JOUR AU - Hoogeveen, R. C. AU - Gaubatz, J. W. AU - Sun, W. AU - Dodge, R. C. AU - Crosby, J. R. AU - Jiang, J. AU - Couper, D. AU - Virani, S. S. AU - Kathiresan, S. AU - Boerwinkle, E. PY - 2014 DA - 2014// TI - Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis risk in communities (ARIC) study JO - Arterioscler Thromb Vasc Biol VL - 34 UR - https://doi.org/10.1161/ATVBAHA.114.303284 DO - 10.1161/ATVBAHA.114.303284 ID - Hoogeveen2014 ER - TY - JOUR AU - Calabresi, L. AU - Franceschini, G. AU - Sirtori, M. AU - Gianfranceschi, G. AU - Werba, P. AU - Sirtori, C. R. PY - 1990 DA - 1990// TI - Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease JO - Atherosclerosis VL - 84 UR - https://doi.org/10.1016/0021-9150(90)90006-5 DO - 10.1016/0021-9150(90)90006-5 ID - Calabresi1990 ER - TY - JOUR AU - Ito, Y. AU - Satoh, N. AU - Ishii, T. AU - Kumakura, J. AU - Hirano, T. PY - 2014 DA - 2014// TI - Development of a homogeneous assay for measurement of high-density lipoprotein-subclass cholesterol JO - Clin Chim Acta VL - 427 UR - https://doi.org/10.1016/j.cca.2013.09.009 DO - 10.1016/j.cca.2013.09.009 ID - Ito2014 ER - TY - JOUR AU - Ashmaig, M. AU - Gupta, S. AU - McConnell, J. P. AU - Warnick, G. R. PY - 2013 DA - 2013// TI - Valiation of a novel homogenous assay for HDL3-C maeasurement JO - Clin Chim Acta VL - 425 UR - https://doi.org/10.1016/j.cca.2013.07.007 DO - 10.1016/j.cca.2013.07.007 ID - Ashmaig2013 ER - TY - JOUR AU - Nauck, M. A. PY - 2014 DA - 2014// TI - Update on developments with SGLT2 inhibitors in the management of type 2 diabetes JO - Drug Des Devel Ther VL - 8 UR - https://doi.org/10.2147/DDDT.S50773 DO - 10.2147/DDDT.S50773 ID - Nauck2014 ER - TY - JOUR AU - Hirose, T. AU - Teramoto, T. AU - Abe, K. AU - Taneyama, T. PY - 2015 DA - 2015// TI - Determinant of bezafibrate-induced improvements in LDL cholesterol in dyslipidemic patients with diabetes JO - J Atheroscler Thromb VL - 22 UR - https://doi.org/10.5551/jat.27425 DO - 10.5551/jat.27425 ID - Hirose2015 ER - TY - JOUR AU - Schacky, C. PY - 2006 DA - 2006// TI - A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels JO - Vasc Health Risk Manag VL - 2 UR - https://doi.org/10.2147/vhrm.2006.2.3.251 DO - 10.2147/vhrm.2006.2.3.251 ID - Schacky2006 ER - TY - JOUR AU - Berneis, K. K. AU - Krauss, R. M. PY - 2002 DA - 2002// TI - Metabolic origins and clinical significance of LDL heterogeneity JO - J Lipid Res VL - 43 UR - https://doi.org/10.1194/jlr.R200004-JLR200 DO - 10.1194/jlr.R200004-JLR200 ID - Berneis2002 ER - TY - JOUR AU - Annuzzi, G. AU - Natale, C. AU - Iovine, C. AU - Patti, L. AU - Marino, L. AU - Coppola, S. AU - Prato, S. AU - Riccardi, G. AU - Rivellese, A. A. PY - 2004 DA - 2004// TI - Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus JO - Arterioscler Thromb Vasc Biol VL - 24 UR - https://doi.org/10.1161/01.ATV.0000146267.71816.30 DO - 10.1161/01.ATV.0000146267.71816.30 ID - Annuzzi2004 ER - TY - JOUR AU - Schernthaner, G. AU - Matthews, D. R. AU - Charbonnel, B. AU - Hanefeld, M. AU - Brunetti, P. PY - 2004 DA - 2004// TI - Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2003-030861 DO - 10.1210/jc.2003-030861 ID - Schernthaner2004 ER - TY - JOUR AU - Dormandy, J. A. AU - Charbonnel, B. AU - Eckland, D. J. AU - Erdmann, E. AU - Massi-Benedetti, M. AU - Moules, I. K. AU - Skene, A. M. AU - Tan, M. H. AU - Lefèbvre, P. J. AU - Murray, G. D. PY - 2005 DA - 2005// TI - Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67528-9 DO - 10.1016/S0140-6736(05)67528-9 ID - Dormandy2005 ER - TY - JOUR AU - Briand, F. AU - Mayoux, E. AU - Brousseau, E. AU - Burr, N. AU - Urbain, I. AU - Costard, C. AU - Mark, M. AU - Sulpice, T. PY - 2016 DA - 2016// TI - Empagliflozin, via switching metabolism towards lipid utilization, moderately increases LDL-cholesterol levels through reduced LDL catabolism JO - Diabetes VL - 65 UR - https://doi.org/10.2337/db16-0049 DO - 10.2337/db16-0049 ID - Briand2016 ER - TY - JOUR AU - Okazaki, M. AU - Usui, S. AU - Ishigami, M. AU - Sakai, N. AU - Nakamura, T. AU - Matsuzawa, Y. AU - Yamashita, S. PY - 2005 DA - 2005// TI - Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography JO - Arterioscler Thromb Vasc Biol VL - 25 UR - https://doi.org/10.1161/01.ATV.0000155017.60171.88 DO - 10.1161/01.ATV.0000155017.60171.88 ID - Okazaki2005 ER - TY - JOUR AU - Yabe, D. AU - Seino, Y. AU - Fukushima, M. AU - Seino, S. PY - 2015 DA - 2015// TI - β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians JO - Curr Diab Rep VL - 15 UR - https://doi.org/10.1007/s11892-015-0602-9 DO - 10.1007/s11892-015-0602-9 ID - Yabe2015 ER - TY - JOUR AU - Kaku, K. AU - Kiyosue, A. AU - Inoue, S. AU - Ueda, N. AU - Tokudome, T. AU - Yang, J. AU - Langkilde, A. M. PY - 2014 DA - 2014// TI - Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise JO - Diabetes Obes Metab VL - 16 UR - https://doi.org/10.1111/dom.12325 DO - 10.1111/dom.12325 ID - Kaku2014 ER - TY - JOUR AU - St-Pierre, A. C. AU - Cantin, B. AU - Dagenais, G. R. AU - Mauriège, P. AU - Bernard, P. M. AU - Després, J. P. AU - Lamarche, B. PY - 2005 DA - 2005// TI - Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men, 13-year follow-up data from the Québec cardiovascular study JO - Arterioscler Thromb Vasc Biol VL - 25 UR - https://doi.org/10.1161/01.ATV.0000154144.73236.f4 DO - 10.1161/01.ATV.0000154144.73236.f4 ID - St-Pierre2005 ER - TY - JOUR AU - Tsunoda, F. AU - Koba, S. AU - Hirano, T. AU - Ban, Y. AU - Iso, Y. AU - Suzuki, H. AU - Geshi, E. AU - Katagiri, T. PY - 2004 DA - 2004// TI - Association between small dense low-density lipoprotein and postprandial accumulation of triglyceride-rich remnant-like particles in normotriglyceridemic patients with myocardial infarction JO - Circ J VL - 68 UR - https://doi.org/10.1253/circj.68.1165 DO - 10.1253/circj.68.1165 ID - Tsunoda2004 ER - TY - JOUR AU - Bolinder, J. AU - Ljunggren, Ö. AU - Kullberg, J. AU - Johansson, L. AU - Wilding, J. AU - Langkilde, A. M. AU - Sugg, J. AU - Parikh, S. PY - 2012 DA - 2012// TI - Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin JO - J Clin Endocrinol Metab VL - 97 UR - https://doi.org/10.1210/jc.2011-2260 DO - 10.1210/jc.2011-2260 ID - Bolinder2012 ER - TY - JOUR AU - Wilding, J. P. AU - Woo, V. AU - Soler, N. G. AU - Pahor, A. AU - Sugg, J. AU - Rohwedder, K. AU - Parikh, S. PY - 2012 DA - 2012// TI - Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial JO - Ann Intern Med. VL - 156 UR - https://doi.org/10.7326/0003-4819-156-6-201203200-00003 DO - 10.7326/0003-4819-156-6-201203200-00003 ID - Wilding2012 ER - TY - JOUR AU - Vernon, G. AU - Baranova, A. AU - Younossi, Z. M. PY - 2011 DA - 2011// TI - Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults JO - Aliment Pharmacol Ther VL - 34 UR - https://doi.org/10.1111/j.1365-2036.2011.04724.x DO - 10.1111/j.1365-2036.2011.04724.x ID - Vernon2011 ER - TY - JOUR AU - Siddiqui, M. S. AU - Sterling, R. K. AU - Luketic, V. A. AU - Puri, P. AU - Stravitz, R. T. AU - Bouneva, I. AU - Boyett, S. AU - Fuchs, M. AU - Sargeant, C. AU - Warnick, G. R. PY - 2013 DA - 2013// TI - Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis JO - Gastroenterology VL - 145 UR - https://doi.org/10.1053/j.gastro.2013.08.036 DO - 10.1053/j.gastro.2013.08.036 ID - Siddiqui2013 ER - TY - JOUR AU - Siddiqui, M. S. AU - Fuchs, M. AU - Idowu, M. O. AU - Luketic, V. A. AU - Boyett, S. AU - Sargeant, C. AU - Stravitz, R. T. AU - Puri, P. AU - Matherly, S. AU - Sterling, R. K. PY - 2015 DA - 2015// TI - Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile JO - Clin Gastroenterol Hepatol VL - 13 UR - https://doi.org/10.1016/j.cgh.2014.10.008 DO - 10.1016/j.cgh.2014.10.008 ID - Siddiqui2015 ER - TY - JOUR AU - Musso, G. AU - Gambino, R. AU - Durazzo, M. AU - Biroli, G. AU - Carello, M. AU - Fagà, E. AU - Pacini, G. AU - Michieli, F. AU - Rabbione, L. AU - Premoli, A. PY - 2005 DA - 2005// TI - Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease JO - Hepatology VL - 42 UR - https://doi.org/10.1002/hep.20896 DO - 10.1002/hep.20896 ID - Musso2005 ER - TY - JOUR AU - Ostlund, R. E. AU - Staten, M. AU - Kohrt, W. M. AU - Schultz, J. AU - Malley, M. PY - 1990 DA - 1990// TI - The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults JO - N Engl J Med VL - 322 UR - https://doi.org/10.1056/NEJM199001253220404 DO - 10.1056/NEJM199001253220404 ID - Ostlund1990 ER - TY - JOUR AU - Hwang, Y. C. AU - Hayashi, T. AU - Fujimoto, W. Y. AU - Kahn, S. E. AU - Leonetti, D. L. AU - McNeely, M. J. AU - Boyko, E. J. PY - 2015 DA - 2015// TI - Differential association between HDL subclass and the development of type 2 diabetes in prospective study of Japanese Americans JO - Diabetes Care VL - 38 UR - https://doi.org/10.2337/dc15-0625 DO - 10.2337/dc15-0625 ID - Hwang2015 ER - TY - JOUR AU - Sonesson, C. AU - Johansson, P. A. AU - Johnsson, E. AU - Gause-Nilsson, I. PY - 2016 DA - 2016// TI - Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0356-y DO - 10.1186/s12933-016-0356-y ID - Sonesson2016 ER - TY - JOUR AU - Fioretto, P. AU - Mansfield, T. A. AU - Ptaszynska, A. AU - Yavin, Y. AU - Johnsson, E. AU - Parikh, S. PY - 2016 DA - 2016// TI - Long-term safety of dapagliflozin in older patients with type 2 diabetes mellitus: a pooled analysis of phase IIb/III studies JO - Drugs Aging VL - 33 UR - https://doi.org/10.1007/s40266-016-0382-1 DO - 10.1007/s40266-016-0382-1 ID - Fioretto2016 ER - TY - STD TI - Li FF, Gao G, Li Q, Zhu HH, Su XF, Wu JD, Ye L, Ma JH. Influence of dapagliflozin on glycemic variations in patients with newly diagnosed type 2 diabetes mellitus. J Diabetes Res. 2016. ID - ref45 ER - TY - JOUR AU - Nakamura, T. AU - Iwanaga, Y. AU - Miyaji, Y. AU - Nohara, R. AU - Ishimura, T. AU - Miyazaki, S. PY - 2016 DA - 2016// TI - Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0371-z DO - 10.1186/s12933-016-0371-z ID - Nakamura2016 ER - TY - JOUR AU - Horton, E. S. AU - Silberman, C. AU - Davis, K. L. AU - Berria, R. PY - 2010 DA - 2010// TI - Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc09-2062 DO - 10.2337/dc09-2062 ID - Horton2010 ER - TY - JOUR AU - Monami, M. AU - Vitale, V. AU - Ambrosio, M. L. AU - Bartoli, N. AU - Toffanello, G. AU - Ragghianti, B. AU - Monami, F. AU - Marchionni, N. AU - Mannucci, E. PY - 2012 DA - 2012// TI - Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controled trials JO - Adv Ther VL - 29 UR - https://doi.org/10.1007/s12325-012-0045-5 DO - 10.1007/s12325-012-0045-5 ID - Monami2012 ER - TY - JOUR AU - Matikainen, N. AU - Mänttäri, S. AU - Schweizer, A. AU - Ulvestad, A. AU - Mills, D. AU - Dunning, B. E. AU - Foley, J. E. AU - Taskinen, M. R. PY - 2006 DA - 2006// TI - Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes JO - Diabetologia VL - 49 UR - https://doi.org/10.1007/s00125-006-0340-2 DO - 10.1007/s00125-006-0340-2 ID - Matikainen2006 ER - TY - JOUR AU - Matikainen, N. AU - Taskinen, M. R. PY - 2013 DA - 2013// TI - The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes JO - Diabet Med VL - 30 UR - https://doi.org/10.1111/dme.12094 DO - 10.1111/dme.12094 ID - Matikainen2013 ER -